Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Know Labs, Inc. Common Stock (NY:KNW)

2.140 UNCHANGED
Last Price Updated: 8:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Know Labs, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2023 Results on May 15, 2023
From Know Labs, Inc.
Via Business Wire
Know Labs Study Validates Technical Feasibility of its Novel Sensor for Non-Invasive Glucose Monitoring
From Know Labs, Inc.
Via Business Wire
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment. 
Via Benzinga
Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study
From Know Labs, Inc.
Via Business Wire
Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation as First Members
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Reports First Quarter 2023 Results
From Know Labs, Inc.
Via Business Wire
Know Labs (KNW) Stock Falls on IPO
Know Labs was able to upsize its IPO offer from 3 million shares at $2 up to 3.6 million shares at $2. KNW stock is mixed in trading though. 
Via InvestorPlace
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. 
Via Benzinga
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2023 Results on February 14, 2023
From Know Labs, Inc.
Via Business Wire
Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application
From Know Labs, Inc.
Via Business Wire
Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Expands IP Leadership in Non-Invasive Diagnostics with New High Performance Glucose Sensor Patent
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2022 Results
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Addresses False and Incomplete Short Seller’s Claims
From Know Labs, Inc.
Via Business Wire
Earnings Scheduled For December 20, 2022
Companies Reporting Before The Bell • Treasure Global (NASDAQ:TGL) is likely to report earnings for its first quarter. 
Via Benzinga
Know Labs, Inc. to Host Review of Fiscal Year 2022 Results on December 20, 2022
From Know Labs, Inc.
Via Business Wire
Medical Tech Company Concludes Successful Uplist to NYSE American
By David Willey, Benzinga 
Via News Direct
Medical Tech Company Concludes Successful Uplist to NYSE American
A U.S.-based medical device company recently completed its successful uplisting to the New York Stock Exchange (NYSE) American exchange. Know Labs Inc. (NYSEAMERICAN: KNW) raised over $8 million from... 
Via TheNewswire.com
Know Labs Participating in Second Annual Bernstein CGM Disruptors Conference
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock
From Know Labs, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.